Report of Foreign Issuer (6-k)
December 22 2016 - 5:17PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT
TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934
For the month of
December, 2016
|
|
Commission File Number
000-29338
|
CARDIOME PHARMA CORP.
|
(Translation of registrant's name into English)
|
1441 Creekside Drive, 6th Floor
Vancouver, British Columbia, Canada V6J
4S7
|
(Address of principal executive offices)
|
Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F
Form 40-F
X
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
DOCUMENTS INCLUDED AS PART OF THIS REPORT
Exhibit
|
Description
|
|
|
99.1
|
Amendment No. 1, dated December 22, 2016, to the Purchase Agreement, dated January 12, 2016, between Cardiome Pharma Corp. and Lincoln Park Capital Fund, LLC
|
Exhibit 99.1 of this report on Form 6-K is incorporated by
reference into the Company’s registration statement on Form F-10 (File No. 333-193645) and registration statements on Form
S-8 (File No. 333-199091 and File No. 333-199092).
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
|
|
|
CARDIOME
PHARMA CORP.
|
|
|
|
(Registrant)
|
|
|
|
|
|
|
Date:
|
December 22, 2016
|
|
By:
|
/S/ JENNIFER ARCHIBALD
|
|
|
|
|
Name:
|
Jennifer Archibald
|
|
|
|
|
Title:
|
Chief Financial Officer
|
Correvio Pharma (NASDAQ:CORV)
Historical Stock Chart
From Mar 2024 to Apr 2024
Correvio Pharma (NASDAQ:CORV)
Historical Stock Chart
From Apr 2023 to Apr 2024